Key result
The Cepheid Xpert Xpress Flu/RSV assay demonstrated 100% agreement for influenza A and B, 96.7% for RSV, and 99.7% for negative results compared to in-house RT-PCR in clinical respiratory samples.
Why the study?
Does the Cepheid Xpert Xpress Flu/RSV assay perform comparably to an in-house FluAB/RSV triplex real-time RT-PCR assay for detecting Influenza A, B, and RSV in respiratory specimens?
Cross-Sectional (n=192)
Does the Cepheid Xpert Xpress Flu/RSV assay perform comparably to an in-house FluAB/RSV triplex real-time RT-PCR assay for detecting Influenza A, B, and RSV in respiratory specimens?
The Xpert Xpress Flu/RSV assay demonstrates excellent diagnostic agreement with in-house RT-PCR, offering a rapid alternative for patient triage during influenza epidemics.
No takes yet. Share an insight, caveat, or question.
May enable faster respiratory virus triage in labs; supports but does not replace larger validation studies.
Ho et al. (2018) conducted a cross-sectional in Influenza A, Influenza B, and Respiratory Syncytial Virus (n=192). Cepheid Xpert Xpress Flu/RSV assay vs. in-house FluAB/RSV triplex real-time RT-PCR assay was evaluated on Agreement rate between the two assays for detection of influenza A, influenza B, and RSV. The Cepheid Xpert Xpress Flu/RSV assay demonstrated 100% agreement for influenza A and B, 96.7% for RSV, and 99.7% for negative results compared to in-house RT-PCR in clinical respiratory samples.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: